RxDoctor Payments DataLook up a doctor →

Michael Killpack

Internal Medicine · Sandy, UTNPI 1588714091

Payments from drug & device makers

$2,003,377in general payments, 2019–2025

Across 518 payments — averaging $3867.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$495K
  • Eisai Inc.$320K
  • Sebela Pharmaceuticals Inc.$248K
  • Mitsubishi Tanabe Pharma Development America, Inc.$231K
  • Biohaven Pharmaceuticals, Inc.$221K
  • AstraZeneca$111K
  • plus $378K from 32 others
$5,403in research payments, 2019–2025

Across 3 payments — averaging $1801.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$5K

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,003,377 in reported general payments places this provider in the 95th percentile of 496 internal medicine providers in Utah.

See all internal medicine providers in Utah

Other internal medicine in Sandy

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →